| 700448 |
FRONTIERS IN ONCOLOGY |
miR-27-3p Enhances the Sensitivity of Triple-Negative Breast Cancer Cells to the Antitumor Agent Olaparib by Targeting PSEN-1, the Catalytic Subunit of Γ-Secretase |
2021-06-08 |
10.3389/fonc.2021.694491 |
Zhao Meng, Sun Baisheng, Wang Yan, Qu Gengbao, Yang Hua, Wang Pilin |
| 700447 |
FRONTIERS IN ONCOLOGY |
NEK2 Promotes Cell Proliferation and Glycolysis by Regulating PKM2 Abundance via Phosphorylation in Diffuse Large B-Cell Lymphoma |
2021-06-08 |
10.3389/fonc.2021.677763 |
Zhou Lingna, Ding Liya, Gong Yuqi, Zhao Jing, Zhang Jing, Mao Zhengrong, Wang Zhe, Zhang Wei, Zhou Ren |
| 700446 |
FRONTIERS IN ONCOLOGY |
Bromodomain Inhibition Attenuates the Progression and Sensitizes the Chemosensitivity of Osteosarcoma by Repressing GP130/STAT3 Signaling |
2021-06-08 |
10.3389/fonc.2021.642134 |
Jiang Yafei, Wang Gangyang, Mu Haoran, Ma Xiaojun, Wang Zhuoying, Lv Yu, Zhang Tao, Xu Jing, Wang Jinzeng, Li Yunqi, Han Jing, Yang Mengkai, Wang Zongyi, Zeng Ke, Jin Xinmeng, Xue Song, Yin Mingzhu, Sun Wei, Hua Yingqi, Cai Zhengdong |
| 700445 |
FRONTIERS IN ONCOLOGY |
N6-Methyladenosine Modification of LncRNA DUXAP9 Promotes Renal Cancer Cells Proliferation and Motility by Activating the PI3K/AKT Signaling Pathway |
2021-06-08 |
10.3389/fonc.2021.641833 |
Tan Lei, Tang Yiming, Li Hongbo, Li Pengju, Ye Yunlin, Cen Junjie, Gui Chengpeng, Luo Junhang, Cao Jiazheng, Wei Jinhuan |
| 700444 |
FRONTIERS IN ONCOLOGY |
A Liquid-Liquid Phase Separation-Related Gene Signature as Prognostic Biomarker for Epithelial Ovarian Cancer |
2021-06-08 |
10.3389/fonc.2021.671892 |
Qiu Yan, Pan Min, Chen Xuemei |
| 700443 |
FRONTIERS IN ONCOLOGY |
Profiling of 520 Candidate Genes in 50 Surgically Treated Chinese Small Cell Lung Cancer Patients |
2021-06-08 |
10.3389/fonc.2021.644434 |
Yuan Ting, Wang Xin, Sun Sijin, Cao Zheng, Feng Xiaoli, Gao Yibo |
| 700442 |
FRONTIERS IN ONCOLOGY |
Case Report: EGFR-Positive Early-Stage Lung Adenocarcinoma Transforming to Squamous Cell Carcinoma After TKI Treatment |
2021-06-08 |
10.3389/fonc.2021.696881 |
Liao Jiatao, Li Yuan, Liu Chang, Long Qianqian, Wang Jialei |
| 700441 |
FRONTIERS IN ONCOLOGY |
A Systematic Review and Meta-Analysis of Randomized Controlled Trials With Novel Hormonal Therapies for Non-Metastatic Castration-Resistant Prostate Cancer: An Update From Mature Overall Survival Data |
2021-06-08 |
10.3389/fonc.2021.700258 |
Maggi Martina, Salciccia Stefano, Del Giudice Francesco, Busetto Gian Maria, Falagario Ugo G., Carrieri Giuseppe, Ferro Matteo, Porreca Angelo, Di Pierro Giovanni Battista, Fasulo Vittorio, Frantellizzi Viviana, De Vincentis Giuseppe, De Berardinis Ettore, Sciarra Alessandro |
| 700440 |
FRONTIERS IN ONCOLOGY |
CT Radiomics Model for Discriminating the Risk Stratification of Gastrointestinal Stromal Tumors: A Multi-Class Classification and Multi-Center Study |
2021-06-08 |
10.3389/fonc.2021.654114 |
Chen Zhonghua, Xu Linyi, Zhang Chuanmin, Huang Chencui, Wang Minhong, Feng Zhan, Xiong Yue |
| 700439 |
FRONTIERS IN ONCOLOGY |
Functionalized Selenium Nanotherapeutics Synergizes With Zoledronic Acid to Suppress Prostate Cancer Cell Growth Through Induction of Mitochondria-Mediated Apoptosis and Cell Cycle S Phase Arrest |
2021-06-08 |
10.3389/fonc.2021.685784 |
An Yulin, Zhao Jianfu |
